KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Clinical trial NCT06451757 · RECRUITING

Trial details

NCT number: NCT06451757
Sponsor: Khondrion BV
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mitochondrial Diseases Maternally Inherited Diabetes and Deafness (MIDD)Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation

Start date: 2026-04-14
Primary completion: 2028-09-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.